Skip to main content
Contact Us
Subscribe
E-Edition
91°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
113.27
+0.51 (+0.45%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
32
33
34
35
36
37
38
39
Next >
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
November 12, 2021
Johnson & Johnson will split its consumer health unit into a publicly traded company.
Via
Investor's Business Daily
A (Virtual) Field Trip Into the Heart
November 12, 2021
SOURCE: Abbott
Via
3BL Media
2 Dividend Aristocrats That Could Announce Generous Rate Hikes in December
November 11, 2021
Buy now to take advantage of what will likely be higher yields to come.
Via
The Motley Fool
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations
November 09, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – New at-home Covid tests are on the way, according to the Biden administration, which announced...
Via
FinancialNewsMedia
Exposures
COVID-19
Explore the Human Heart: New Virtual Field Trip Premieres Tuesday, Nov. 9
November 08, 2021
SOURCE: Abbott
Via
3BL Media
Real Sustainability Is About People
October 29, 2021
SOURCE: Abbott
Via
3BL Media
10 S&P 500 Stocks to Buy After Winning in Q3
November 05, 2021
Earnings reports for S&P 500 stocks have been exceptionally good so far. Here are 10 stocks to buy that have delivered in Q3.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Engineer Becomes a Mother While Responding to Pandemic
November 05, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
Lilly Stock Receives Key IBD Stock Rating Upgrade; Looking To Extend Its Long Run Higher
November 04, 2021
Lilly stock's Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
Via
Investor's Business Daily
7 Dividend Aristocrat Stocks That Should Grace Your Portfolio
November 03, 2021
You get a lot more more from dividend aristocrat stocks than just a rock-solid dividend. They also promise solid, long-term growth.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Atrial Fibrillation Market Is Expected To Reach $11.123 Billion At A CAGR 11.2 % Through 2023
November 04, 2021
Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations
November 03, 2021
SOURCE: Abbott
Via
3BL Media
Vice President Of Abbott Laboratories Makes $1.0M Sale
October 28, 2021
Philip P Boudreau, Vice President at Abbott Laboratories (NYSE:ABT), made a large insider sell on October 25, according to a new SEC filing. What Happened: A Form 4 filing from...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Edwards Topples As Full-Year Guidance Comes In Light After Mixed Quarter
October 27, 2021
The company retained guidance for adjusted profit of $2.07-$2.27, missing the midpoint of analysts' view.
Via
Investor's Business Daily
Where Abbott Laboratories Stands With Analysts
October 27, 2021
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021
October 27, 2021
Upgrades According to Credit Suisse, the prior rating for Mercer International Inc (NASDAQ:
Via
Benzinga
Got $5,000? These 2 Unstoppable Stocks Are No-Brainer Buys
October 26, 2021
Both are great places to park your money for years.
Via
The Motley Fool
Kimberly-Clark's Earnings Remind Investors that Inflation and Supply Chain Issues are Still a Major Theme
October 25, 2021
This week is a big one for earnings, not just because of the big names reporting but because of the large number of earnings announcements. Investors can expect the themes of...
Via
Benzinga
Will Tech Stocks Derail the 3Q21 Earnings Rally?
October 24, 2021
S&P 500 equities continued to post robust 3rd quarter earnings reports, staying on track to grow EPS by 32.7% year-over-year. Over 84% of those reporting topped analysts’ forecasts. The damage from a...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
AbbVie: A Healthy Idea For Retirement Portfolios
October 23, 2021
The healthcare industry is among the cheapest sectors in today's market, and this pandemic has validated its importance for the economy and our overall well-being. Over the next decade, we will see...
Via
Talk Markets
Topics
Economy
Retirement
Exposures
Economy
Pension
A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO
October 22, 2021
Key takeaways Four rounds of fundraising together with IPO proceeds have given the Abbisko a cumulative war chest of almost $500 million Company is betting a significant portion...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Where Abbott Laboratories Stands With Analysts
October 21, 2021
Over the past 3 months, 4 analysts have published their opinion on Abbott Laboratories (NYSE:
Via
Benzinga
10 Biggest Price Target Changes For Thursday
October 21, 2021
Wedbush boosted Tesla, Inc. (NASDAQ:TSLA) price ...
Via
Benzinga
3 Things Investors Should Love About Abbott's Q3 Results
October 21, 2021
There was nothing but good news for Abbott in Q3.
Via
The Motley Fool
Why Abbott Laboratories Shot Higher Today
October 20, 2021
All four of the company's divisions posted strong growth, but one in particular was a standout.
Via
The Motley Fool
Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript
October 20, 2021
ABT earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector
October 20, 2021
Just before Tuesday’s close, Netflix (NASDAQ: NFLX) reported better-than-expected earnings by adding 4.4 million subscribers in the third quarter. The company...
Via
Benzinga
A Crowded Earnings Calendar Ahead
October 20, 2021
Last week, major banks like Citigroup Inc (NYSE: C), The Goldman Sachs Group (NYSE: GS), and Bank of America Corporation (NYSE: BAC) have reported quarterly results with solid...
Via
Benzinga
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead
October 20, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 20, 2021 – USA News Group – It may have its beginning for the UK travel industry, but there are signs of the end of using...
Via
FinancialNewsMedia
Exposures
COVID-19
Abbott Labs Squashes Quarterly Views As Covid Testing Sales Pop
October 20, 2021
Abbott Laboratories reported $1.9 billion in sales of its Covid tests, rising sequentially.
Via
Investor's Business Daily
< Previous
1
2
...
32
33
34
35
36
37
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.